
Attovia
Developer of biotherapeutics pipeline designed for immune-mediated disease and oncology. The company leverages the nanobody platform, to generate small format binders with low picomolar affinity, enha...
Valuation
$370M
Latest known
Share Price
N/A
Total Raised
$255M
Last Round
N/A